277 related articles for article (PubMed ID: 17504512)
1. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
2. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
3. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
[TBL] [Abstract][Full Text] [Related]
4. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection.
Minaguchi T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
Cancer Res; 1998 Oct; 58(20):4585-6. PubMed ID: 9788606
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
Li CY; Liu JH; Huang BJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
[TBL] [Abstract][Full Text] [Related]
6. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.
Tenti P; Vesentini N; Rondo Spaudo M; Zappatore R; Migliora P; Carnevali L; Ranzani GN
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):435-8. PubMed ID: 10794489
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women.
Lee SA; Kim JW; Roh JW; Choi JY; Lee KM; Yoo KY; Song YS; Kang D
Gynecol Oncol; 2004 Apr; 93(1):14-8. PubMed ID: 15047208
[TBL] [Abstract][Full Text] [Related]
8. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].
Suárez-Rincón AE; Morán-Moguel MC; Montoya-Fuentes H; Gallegos-Arreola MP; Sánchez-Corona J
Ginecol Obstet Mex; 2002 Jul; 70():344-8. PubMed ID: 12221910
[TBL] [Abstract][Full Text] [Related]
9. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk.
Inserra P; Abrahamsen M; Papenfuss M; Giuliano AR
Int J STD AIDS; 2003 Dec; 14(12):800-4. PubMed ID: 14678586
[TBL] [Abstract][Full Text] [Related]
10. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors for cervico-uterine cancer associated to HPV: p53 codon 72 polymorphism in women attending hospital care].
Sifuentes Alvarez A; Reyes Romero M
Ginecol Obstet Mex; 2003 Jan; 71():12-5. PubMed ID: 12708345
[TBL] [Abstract][Full Text] [Related]
12. The p53 codon 72 arg/arg homozygous women in central Italy are at increased risk for HPV infections.
Ciotti M; Coletti A; Giuliani L; Cappiello G; Syrjanen K; Favalli C
Anticancer Res; 2006; 26(5B):3745-8. PubMed ID: 17094395
[TBL] [Abstract][Full Text] [Related]
13. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
[TBL] [Abstract][Full Text] [Related]
14. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer.
Dokianakis DN; Spandidos DA
Mol Cell Biol Res Commun; 2000 Feb; 3(2):111-4. PubMed ID: 10775508
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
[TBL] [Abstract][Full Text] [Related]
16. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.
Santos AM; Sousa H; Catarino R; Pinto D; Pereira D; Vasconcelos A; Matos A; Lopes C; Medeiros R
Cancer Genet Cytogenet; 2005 Jun; 159(2):143-7. PubMed ID: 15899386
[TBL] [Abstract][Full Text] [Related]
17. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China.
Li T; Lu ZM; Guo M; Wu QJ; Chen KN; Xing HP; Mei Q; Ke Y
Cancer; 2002 Dec; 95(12):2571-6. PubMed ID: 12467072
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients.
Gudleviciene Z; Didziapetriene J; Ramael M; Uleckiene S; Valuckas KP
Gynecol Oncol; 2006 Sep; 102(3):530-3. PubMed ID: 16488468
[TBL] [Abstract][Full Text] [Related]
19. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
20. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.
Storey A; Thomas M; Kalita A; Harwood C; Gardiol D; Mantovani F; Breuer J; Leigh IM; Matlashewski G; Banks L
Nature; 1998 May; 393(6682):229-34. PubMed ID: 9607760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]